Employers are increasingly recognizing the need to develop more cost-effective ways to provide prescription drug benefits to employees. One Fortune 500 company reduced total drug costs by putting PBMs on the chopping block, and creating direct-to-pharmacy agreements. Identifying innovative approaches to delivering prescription drug benefits is a growing trend among major companies. PBM reform is long overdue not only for large companies, but also for federal government programs. To learn more, read B. Douglas Hoey’s opinion contribution to The Hill here.